Drugs / Candida albicans Skin Test Antigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01757392 | Sep 2012 → Dec 2014 | common wart, human papilloma virus infection | Nielsen BioSciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Candida albicans Skin Test Antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01757392 ↗ |
| Route | Other | “0.3 ml injected intralesionally monthly.” NCT01757392 ↗ |